Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yuanheng Solid Beverage is a Traditional Chinese Medicine (TCM)-based nutraceutical developed by Shuguang Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically formulated to address mitochondrial dysfunction and age-related physiological decline. The product is composed of a synergistic blend of botanical extracts, including *Panax ginseng*, *Astragalus membranaceus*, and *Epimedium brevicornu*, which are traditionally used in TCM for their tonifying and anti-aging properties. Research indicates that Yuanheng Solid Beverage works by activating the SIRT1/PGC-1α signaling pathway, which in turn promotes mitochondrial biogenesis, enhances mitochondrial respiratory chain function, and improves cellular energy metabolism. It is primarily investigated for its potential to slow the aging process and treat conditions associated with mitochondrial impairment, such as sarcopenia and age-related fatigue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yuanheng Solid Beverage.